119 related articles for article (PubMed ID: 2713698)
1. Repeated haloperidol administration changes basal release of striatal dopamine and subsequent response to haloperidol challenge.
Zhang W; Tilson H; Stachowiak MK; Hong JS
Brain Res; 1989 Apr; 484(1-2):389-92. PubMed ID: 2713698
[TBL] [Abstract][Full Text] [Related]
2. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
See RE
Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879
[TBL] [Abstract][Full Text] [Related]
3. Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [3H]spiperone binding.
Van der Krogt JA; Van Valkenburg CF; Belfroid RD; Heerkens CB
Eur J Pharmacol; 1988 Dec; 158(1-2):29-35. PubMed ID: 3220118
[TBL] [Abstract][Full Text] [Related]
4. Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis.
Hernandez L; Hoebel BG
Brain Res Bull; 1989 Apr; 22(4):763-9. PubMed ID: 2736403
[TBL] [Abstract][Full Text] [Related]
5. Effect of chloral hydrate on in vivo KCl-induced striatal dopamine release in the rat.
Chen HT; Kandasamy SB
Neurochem Res; 1996 Jun; 21(6):695-700. PubMed ID: 8829142
[TBL] [Abstract][Full Text] [Related]
6. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.
Zhang WQ; Tilson HA; Nanry KP; Hudson PM; Hong JS; Stachowiak MK
Brain Res; 1988 Oct; 461(2):335-42. PubMed ID: 3141002
[TBL] [Abstract][Full Text] [Related]
7. Development of haloperidol-induced dopamine release in the rat striatum using intracerebral dialysis.
Walters DE; Chapman CD; Howard SG
J Neurochem; 1990 Jan; 54(1):181-6. PubMed ID: 2293609
[TBL] [Abstract][Full Text] [Related]
8. Restorative effects of GDNF on striatal dopamine release in rats treated with neurotoxic doses of methamphetamine.
Cass WA; Manning MW; Bailey SL
Ann N Y Acad Sci; 2000 Sep; 914():127-36. PubMed ID: 11085315
[TBL] [Abstract][Full Text] [Related]
9. Halothane attenuated haloperidol and enhanced clozapine-induced dopamine release in the rat striatum.
Adachi YU; Aramaki Y; Satomoto M; Higuchi H; Watanabe K
Neurochem Int; 2003 Jul; 43(2):113-9. PubMed ID: 12620279
[TBL] [Abstract][Full Text] [Related]
10. Changes in striatal dopamine release and metabolism during and after subchronic haloperidol administration in rats.
See RE; Murray CE
Neurosci Lett; 1992 Aug; 142(1):100-4. PubMed ID: 1383895
[TBL] [Abstract][Full Text] [Related]
11. Acute versus chronic haloperidol: relationship between tolerance to catalepsy and striatal and accumbens dopamine, GABA and acetylcholine release.
Osborne PG; O'Connor WT; Beck O; Ungerstedt U
Brain Res; 1994 Jan; 634(1):20-30. PubMed ID: 7908848
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats.
Bettini E; Ceci A; Spinelli R; Samanin R
Biochem Pharmacol; 1987 Jul; 36(14):2387-91. PubMed ID: 2886127
[TBL] [Abstract][Full Text] [Related]
13. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
[TBL] [Abstract][Full Text] [Related]
14. Decrease in the evoked release of endogenous dopamine and dihydroxyphenylacetic acid from rat striatal slices after withdrawal from repeated haloperidol.
Umeda Y; Sumi T
Eur J Pharmacol; 1990 Nov; 191(2):149-55. PubMed ID: 2086236
[TBL] [Abstract][Full Text] [Related]
15. Ontogeny of tolerance to haloperidol: behavioral and biochemical measures.
Coyle S; Napier TC; Breese GR
Brain Res; 1985 Nov; 355(1):27-38. PubMed ID: 4075104
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
Commissiong JW; Slimovitch C; Toffano G
Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
[TBL] [Abstract][Full Text] [Related]
17. Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing.
Csernansky JG; Bellows EP; Barnes DE; Lombrozo L
Psychopharmacology (Berl); 1990; 101(4):519-24. PubMed ID: 2388975
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1991 Jan; 256(1):348-57. PubMed ID: 1703232
[TBL] [Abstract][Full Text] [Related]
19. Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment.
Ichikawa J; Meltzer HY
Brain Res; 1990 Jan; 507(1):138-42. PubMed ID: 2302571
[TBL] [Abstract][Full Text] [Related]
20. Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis.
Imperato A; Di Chiara G
J Neurosci; 1985 Feb; 5(2):297-306. PubMed ID: 2857776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
